Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy.
Yang R, Sun L, Li CF, Wang YH, Yao J, Li H, Yan M, Chang WC, Hsu JM, Cha JH, Hsu JL, Chou CW, Sun X, Deng Y, Chou CK, Yu D, Hung MC.
Yang R, et al. Among authors: chou cw, chou ck.
Nat Commun. 2021 Feb 5;12(1):832. doi: 10.1038/s41467-021-21099-2.
Nat Commun. 2021.
PMID: 33547304
Free PMC article.